Stefan Spulber
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Stefan Spulber has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
- Sandra Ceccatelli
Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden
14 shared publications - Marianne Schultzberg
Department of Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Center for Alzheimer Research, Karolinska Institutet, Stockholm, Sweden
12 shared publications Bengt Winblad
Department of Neurobiology, Care Sciences and Society, Division of Neurodegeneration, Karolinska Institutet, Stockholm, Sweden
9 shared publicationsMircea Oprica
8 shared publicationsSandra Ceccatelli
Department of Neuroscience, Karolinska Institutet, Sweden
5 shared publicationsClaes Post
Department of Neurobiology, Care Sciences and Society, Karolinska Institutet
4 shared publications
Latest Publications
- Open Access
- 12 April 2026
- Published by SAGE Publications in Cephalalgia
- Vol. 46 (4)
Genetic variability within molecular core clock genes in cluster headache
Background / Hypothesis: Headache attacks are reported to occur with circadian rhythmicity by 2/3 of individuals with cluster headache, hinting to potential dysfunctions of the molecular clock. The aim of this study was to investigate the contribution of genetic markers in core clock genes, alone or in combinations, to the genetic risk for cluster headache. Methods: Seven markers in core clock genes BMAL1 and NPAS2 were genotyped using TaqMan qPCR in 707 individuals with cluster headache and 682 controls. Genetic data from eleven additional markers located in six other core clock genes ( CLOCK , CRY1-2 , and PER1-3 ) was obtained from the database of the Centre for Cluster Headache at Karolinska Institutet. Genotype analysis was applied for risk analysis for combinations of up to three markers. For validation we used a cluster headache cohort from the National Hospital for Neurology and Neurosurgery, London, UK. Results and interpretation: Single marker analysis of the newly genotyped markers in BMAL1 and NPAS2 found rs3789327 and rs3768984 more frequently among individuals with cluster headache (p < 0.01 and p < 0.05 respectively). Multiallelic analysis revealed that the median number of risk alleles was eight for controls and nine for individuals with cluster headache, which justifies the analysis of combinations of markers. The analysis of combinations of up to three markers identified 258 out of 897 combinations to be associated with significant risk. Further investigation starting from the function of genes in the molecular clock transcription-translation feedback loop (TTFL) found that 80% of the combinations had >50% markers located in the positive arm of the TTFL. The comparison between Swedish and UK cohorts identified 39 concordant combinations, which confirmed the risk associated with rs3768984 ( NPAS2 ), as well as the enrichment in markers in BMAL1 , CLOCK , and NPAS2 in combinations associated with significant risk. Conclusion: Our data points to molecular clock dysfunction playing a central role in the manifestation of cluster headache.
- 12 April 2026
- Published by SAGE Publications in Cephalalgia
- Vol. 46 (4)
Open AccessGenetic variability within molecular core clock genes in cluster headache
Background / Hypothesis: Headache attacks are reported to occur with circadian rhythmicity by 2/3 of individuals with cluster headache, hinting to potential dysfunctions of the molecular clock. The aim of this study was to investigate the contribution of genetic markers in core clock genes, alone or in combinations, to the genetic risk for cluster headache. Methods: Seven markers in core clock genes BMAL1 and NPAS2 were genotyped using TaqMan qPCR in 707 individuals with cluster headache and 682 controls. Genetic data from eleven additional markers located in six other core clock genes ( CLOCK , CRY1-2 , and PER1-3 ) was obtained from the database of the Centre for Cluster Headache at Karolinska Institutet. Genotype analysis was applied for risk analysis for combinations of up to three markers. For validation we used a cluster headache cohort from the National Hospital for Neurology and Neurosurgery, London, UK. Results and interpretation: Single marker analysis of the newly genotyped markers in BMAL1 and NPAS2 found rs3789327 and rs3768984 more frequently among individuals with cluster headache (p < 0.01 and p < 0.05 respectively). Multiallelic analysis revealed that the median number of risk alleles was eight for controls and nine for individuals with cluster headache, which justifies the analysis of combinations of markers. The analysis of combinations of up to three markers identified 258 out of 897 combinations to be associated with significant risk. Further investigation starting from the function of genes in the molecular clock transcription-translation feedback loop (TTFL) found that 80% of the combinations had >50% markers located in the positive arm of the TTFL. The comparison between Swedish and UK cohorts identified 39 concordant combinations, which confirmed the risk associated with rs3768984 ( NPAS2 ), as well as the enrichment in markers in BMAL1 , CLOCK , and NPAS2 in combinations associated with significant risk. Conclusion: Our data points to molecular clock dysfunction playing a central role in the manifestation of cluster headache.
- Open Access
- 18 March 2026
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 33 (10) , 1960-1978
Glioma-induced DNMT3A reduction in microglia promotes an anti-tumoral phenotype
Glioblastoma, IDH1 wildtype, aggressive primary brain tumors with a dismal prognosis, promote the recruitment of microglia, brain resident innate immune cells, and ultimately their activation toward a tumor-supportive phenotype that increases gliomal proliferation and invasion capability. Here, we report that upon stimulation by glioma cells, microglia transit via a reactive state holding anti-tumoral properties coupled to reduced DNA methyltransferase 3 A (DNMT3A) chromatin occupancy and DNA demethylation that promote the expression of gene sets related to the transforming growth factor beta (TGF-β)-dependent microglial homeostasis and the microglial sensome. We find that upon repression of Dnmt3a expression in microglia, those cells maintain anti-tumoral attributes in vitro and in vivo. In a syngeneic immunocompetent glioblastoma mouse model, brain delivery of antisense oligonucleotide targeting Dnmt3a expression led to microglial activation and reduced tumor growth. Taken together, our results reveal the involvement of DNA demethylation in the control of glioma cells-induced microglia activation and indicate that microglial DNMT3A is a potentially therapeutic target to treat brain neoplasms such as glioblastoma that include a microglial component.
- 18 March 2026
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 33 (10) , 1960-1978
Open AccessGlioma-induced DNMT3A reduction in microglia promotes an anti-tumoral phenotype
Glioblastoma, IDH1 wildtype, aggressive primary brain tumors with a dismal prognosis, promote the recruitment of microglia, brain resident innate immune cells, and ultimately their activation toward a tumor-supportive phenotype that increases gliomal proliferation and invasion capability. Here, we report that upon stimulation by glioma cells, microglia transit via a reactive state holding anti-tumoral properties coupled to reduced DNA methyltransferase 3 A (DNMT3A) chromatin occupancy and DNA demethylation that promote the expression of gene sets related to the transforming growth factor beta (TGF-β)-dependent microglial homeostasis and the microglial sensome. We find that upon repression of Dnmt3a expression in microglia, those cells maintain anti-tumoral attributes in vitro and in vivo. In a syngeneic immunocompetent glioblastoma mouse model, brain delivery of antisense oligonucleotide targeting Dnmt3a expression led to microglial activation and reduced tumor growth. Taken together, our results reveal the involvement of DNA demethylation in the control of glioma cells-induced microglia activation and indicate that microglial DNMT3A is a potentially therapeutic target to treat brain neoplasms such as glioblastoma that include a microglial component.
- Open Access
- 19 August 2025
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 65 (8) , 1294-1307
Characterization of insomnia and sleep quality in a cohort with cluster headache
Objective: The objective of this cross‐sectional study was to investigate the extent of perceived sleep disturbances in a cluster headache cohort, and to compare how sleep is perceived between participants in an active headache bout to participants in a headache‐free remission period.Background: Cluster headache is a primary headache disorder characterized by extremely painful headache attacks. These attacks commonly occur with a circadian rhythm, with a majority of patients experiencing nocturnal attacks. Sleep is affected in patients with cluster headache, but there are many uncertainties regarding the pathophysiological connection between cluster headache and sleep disturbances and to what extent sleep disturbances persist into remission.Methods: A digital survey was sent out to 701 individuals with cluster headache between January and May 2024. The survey contained questions regarding general health, clinical cluster headache phenotype, and questions from the Karolinska Sleep Questionnaire, the Insomnia Severity Index, and the Dysfunctional Beliefs and Attitudes about Sleep‐10. Scores extracted from each questionnaire were compared between study participants in an active bout versus study participants in remission, and study participants in short‐term remission (p < 0.001; sleep quality: aOR = 0.67 [95% CI, 0.53–0.83] p < 0.001; daytime sleepiness: aOR = 0.59 [95% CI, 0.44–0.78] p < 0.001; and dysfunctional beliefs: aOR = 1.03 [95% CI, 1.01–1.04] p = 0.001). Of the participants in an active bout, 46.5% scored above the Insomnia Severity Index threshold indicating moderate to severe insomnia (≥15) and 43.7% were considered as having poor sleep quality (≤3 on the Sleep Quality Index extracted from the Karolinska Sleep Questionnaire). This is in comparison to 22.0% of participants in remission being above the moderate insomnia threshold and 22.0% considered having poor sleep quality. Participants in long‐term remission had better sleep scores overall compared to participants in short‐term remission (insomnia severity: aOR = 1.09 [95% CI, 1.03–1.16] p = 0.005; daytime sleepiness: aOR = 0.67 [95% CI, 0.42–1.02] p = 0.072; and dysfunctional beliefs: aOR = 1.03 [95% CI, 1.01–1.05] p = 0.006).Conclusion: Individuals with cluster headache have a large degree of sleep disturbances that are exacerbated during an active bout and not completely alleviated during remission. Future studies are needed to determine if this gradual change in sleep disturbances after an active bout is due to physiological changes, which slowly revert to baseline levels after an active bout or connected to persisting negative behavioral or cognitive associations between sleep and headache.
- 19 August 2025
- Published by Wiley in Headache: The Journal of Head and Face Pain
- Vol. 65 (8) , 1294-1307
Open AccessCharacterization of insomnia and sleep quality in a cohort with cluster headache
Objective: The objective of this cross‐sectional study was to investigate the extent of perceived sleep disturbances in a cluster headache cohort, and to compare how sleep is perceived between participants in an active headache bout to participants in a headache‐free remission period.Background: Cluster headache is a primary headache disorder characterized by extremely painful headache attacks. These attacks commonly occur with a circadian rhythm, with a majority of patients experiencing nocturnal attacks. Sleep is affected in patients with cluster headache, but there are many uncertainties regarding the pathophysiological connection between cluster headache and sleep disturbances and to what extent sleep disturbances persist into remission.Methods: A digital survey was sent out to 701 individuals with cluster headache between January and May 2024. The survey contained questions regarding general health, clinical cluster headache phenotype, and questions from the Karolinska Sleep Questionnaire, the Insomnia Severity Index, and the Dysfunctional Beliefs and Attitudes about Sleep‐10. Scores extracted from each questionnaire were compared between study participants in an active bout versus study participants in remission, and study participants in short‐term remission (p < 0.001; sleep quality: aOR = 0.67 [95% CI, 0.53–0.83] p < 0.001; daytime sleepiness: aOR = 0.59 [95% CI, 0.44–0.78] p < 0.001; and dysfunctional beliefs: aOR = 1.03 [95% CI, 1.01–1.04] p = 0.001). Of the participants in an active bout, 46.5% scored above the Insomnia Severity Index threshold indicating moderate to severe insomnia (≥15) and 43.7% were considered as having poor sleep quality (≤3 on the Sleep Quality Index extracted from the Karolinska Sleep Questionnaire). This is in comparison to 22.0% of participants in remission being above the moderate insomnia threshold and 22.0% considered having poor sleep quality. Participants in long‐term remission had better sleep scores overall compared to participants in short‐term remission (insomnia severity: aOR = 1.09 [95% CI, 1.03–1.16] p = 0.005; daytime sleepiness: aOR = 0.67 [95% CI, 0.42–1.02] p = 0.072; and dysfunctional beliefs: aOR = 1.03 [95% CI, 1.01–1.05] p = 0.006).Conclusion: Individuals with cluster headache have a large degree of sleep disturbances that are exacerbated during an active bout and not completely alleviated during remission. Future studies are needed to determine if this gradual change in sleep disturbances after an active bout is due to physiological changes, which slowly revert to baseline levels after an active bout or connected to persisting negative behavioral or cognitive associations between sleep and headache.
- Open Access
- 22 January 2025
- Published by Elsevier in Journal of Affective Disorders
- Vol. 375, 118-128
Individual patterns of activity predict the response to physical exercise as an intervention in mild to moderate depression
- 22 January 2025
- Published by Elsevier in Journal of Affective Disorders
- Vol. 375, 118-128
Open AccessIndividual patterns of activity predict the response to physical exercise as an intervention in mild to moderate depression
- Open Access
- 6 August 2024
- Published by Frontiers Media SA in Frontiers in Toxicology
- Vol. 6, 1397477
Decreased activity in zebrafish larvae exposed to glyphosate-based herbicides during development—potential mediation by glucocorticoid receptor
Glyphosate-based herbicides (GBH) are a widely used group of pesticides that have glyphosate (GLY) as main active compound and are used to control a wide range of weeds. Experimental and epidemiological studies point to neurotoxicity and endocrine disruption as main toxic effects. The aim of this study was to investigate the effects of developmental exposure to GLY and GBH on locomotor behavior, and the possible contribution of GR-mediated signaling. We used zebrafish (Danio rerio) larvae in a continuous exposure regimen to GLY or GBH in the rearing medium. Alongside TL wildtype, we used a mutant line carrying a mutation in the GR which prevents the GR from binding to DNA (grs357), as well as a transgenic strain expressing a variant of enhanced green fluorescent protein (d4eGFP) controlled by a promoter carrying multiple GR response elements (SR4G). We found that acute exposure to GBH, but not GLY, activates GR-mediated signaling. Using a continuous developmental exposure regime, we show that wildtype larvae exposed to GBH display decreased spontaneous activity and attenuated response to environmental stimuli, a pattern of alteration similar to the one observed in grs357 mutant larvae. In addition, developmental exposure to GBH has virtually no effects on the behavior of grs357 mutant larvae. Taken together, our data indicate that developmental exposure to GBH has more pronounced effects than GLY on behavior at 5 dpf, and that interference with GR-mediated signaling may have a relevant contribution.
- 6 August 2024
- Published by Frontiers Media SA in Frontiers in Toxicology
- Vol. 6, 1397477
Open AccessDecreased activity in zebrafish larvae exposed to glyphosate-based herbicides during development—potential mediation by glucocorticoid receptor
Glyphosate-based herbicides (GBH) are a widely used group of pesticides that have glyphosate (GLY) as main active compound and are used to control a wide range of weeds. Experimental and epidemiological studies point to neurotoxicity and endocrine disruption as main toxic effects. The aim of this study was to investigate the effects of developmental exposure to GLY and GBH on locomotor behavior, and the possible contribution of GR-mediated signaling. We used zebrafish (Danio rerio) larvae in a continuous exposure regimen to GLY or GBH in the rearing medium. Alongside TL wildtype, we used a mutant line carrying a mutation in the GR which prevents the GR from binding to DNA (grs357), as well as a transgenic strain expressing a variant of enhanced green fluorescent protein (d4eGFP) controlled by a promoter carrying multiple GR response elements (SR4G). We found that acute exposure to GBH, but not GLY, activates GR-mediated signaling. Using a continuous developmental exposure regime, we show that wildtype larvae exposed to GBH display decreased spontaneous activity and attenuated response to environmental stimuli, a pattern of alteration similar to the one observed in grs357 mutant larvae. In addition, developmental exposure to GBH has virtually no effects on the behavior of grs357 mutant larvae. Taken together, our data indicate that developmental exposure to GBH has more pronounced effects than GLY on behavior at 5 dpf, and that interference with GR-mediated signaling may have a relevant contribution.
- 19 July 2024
- Published by EMBL-EBI
zebrafish swimming behaviour
BioStudies – one package for all the data supporting a study
- 19 July 2024
- Published by EMBL-EBI
zebrafish swimming behaviour
BioStudies – one package for all the data supporting a study
- Open Access
Individual patterns of activity predict the response to physical exercise as an intervention in mild to moderate depression
Physical exercise (PE) as antidepressive intervention is a promising alternative, as shown by multiple meta-analyses. However, there is no consensus regarding optimal intensity and duration of exercise, and there are no objective criteria available for personalized indication of treatment. The aims of this study were (1) to evaluate whether individual activity patterns before intervention can predict the response to treatment; and (2) to evaluate whether the patient outcome can be improved by using prior information on treatment efficacy at individual level. The study included subjects with mild to moderate depression randomized to three levels of exercise intensity in the Regassa study. Using a previously developed pipeline for data analysis, we have generated linear regression ensembles to predict the response to treatment using features extracted from actigraphy recordings. To understand the contribution of individual features, we performed a Bayesian analysis of coefficients, and found that different levels of PE intensity yield distinct signatures in enriched feature subsets. Next, we used the trained ensembles for a counterfactual analysis of response and remission rate provided prior knowledge of response to treatment outcome. The response to either PE regime was estimated for all patients, irrespective of original treatment assignment. Each patient was then virtually allocated to the PE regime predicted to yield best outcome, and the response and remission rates were compared against simulated random assignment to treatment. The counterfactual analysis showed that assignment to best individual PE regime yields significantly higher (increase by 28%) remission rates as compared to random assignment to treatment, which is accounted for by improved response in about 32% of the patients as compared to observed treatment outcome. While it is not possible to claim individual protocol optimization, our data suggest it may be possible to identify a PE regime to yield the best results for a patient based on individual circadian patterns of activity.
Open AccessIndividual patterns of activity predict the response to physical exercise as an intervention in mild to moderate depression
Physical exercise (PE) as antidepressive intervention is a promising alternative, as shown by multiple meta-analyses. However, there is no consensus regarding optimal intensity and duration of exercise, and there are no objective criteria available for personalized indication of treatment. The aims of this study were (1) to evaluate whether individual activity patterns before intervention can predict the response to treatment; and (2) to evaluate whether the patient outcome can be improved by using prior information on treatment efficacy at individual level. The study included subjects with mild to moderate depression randomized to three levels of exercise intensity in the Regassa study. Using a previously developed pipeline for data analysis, we have generated linear regression ensembles to predict the response to treatment using features extracted from actigraphy recordings. To understand the contribution of individual features, we performed a Bayesian analysis of coefficients, and found that different levels of PE intensity yield distinct signatures in enriched feature subsets. Next, we used the trained ensembles for a counterfactual analysis of response and remission rate provided prior knowledge of response to treatment outcome. The response to either PE regime was estimated for all patients, irrespective of original treatment assignment. Each patient was then virtually allocated to the PE regime predicted to yield best outcome, and the response and remission rates were compared against simulated random assignment to treatment. The counterfactual analysis showed that assignment to best individual PE regime yields significantly higher (increase by 28%) remission rates as compared to random assignment to treatment, which is accounted for by improved response in about 32% of the patients as compared to observed treatment outcome. While it is not possible to claim individual protocol optimization, our data suggest it may be possible to identify a PE regime to yield the best results for a patient based on individual circadian patterns of activity.
- Open Access
- 23 December 2023
- Published by Elsevier in NeuroToxicology
- p. 3136
WITHDRAWN: Corrigendum to “In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice” NeuroToxicology 83 (2021) 1–13
- 23 December 2023
- Published by Elsevier in NeuroToxicology
- p. 3136
Open AccessWITHDRAWN: Corrigendum to “In utero exposure to dexamethasone causes a persistent and age-dependent exacerbation of the neurotoxic effects and glia activation induced by MDMA in dopaminergic brain regions of C57BL/6J mice” NeuroToxicology 83 (2021) 1–13
- Open Access
Correlations between patterns of activity and the response to treatment yield distinct signatures for different antidepressive treatments
Alterations in circadian patterns of activity have been described in several psychiatric disorders, and in major depressive disorder (MDD) have been associated with symptom severity. The aim of this study was to investigate the correlations between activity patterns and the response to different antidepressive treatments. We used actigraphy recordings acquired in three independent clinical trials investigating the response to internet-delivered cognitive behavioral therapy (iCBT), escitalopram, or ketamine, where symptom severity was assessed on MADRS scale. Data processing procedure was designed to extract features describing individual circadian cycles, as well as the average circadian profile for each subject. The analysis of effects of antidepressive treatments on single features (independently from magnitude of response) showed alterations in treatment-specific subsets of features. Further analysis revealed distinct correlations between longitudinal changes in individual features and the response to iCBT, escitalopram, or ketamine. Linear regression ensembles modeling the response to treatment were trained on actigraphy recorded during the depressive episode, before intervention. The analysis of coefficients following Bayesian model averaging showed that better response to iCBT was associated with weaker circadian entrainment; better response to ketamine was associated with more robust circadian entrainment and higher fragmentation of activity patterns; while higher age and steeper propensity to sustain activity was associated with better response to either iCBT or ketamine. Our data suggest that the analysis of circadian patterns of activity can potentially be used for predicting the response to specific MDD treatments, however larger confirmatory studies are required. Highlights: Different antidepressant treatments alter specific subsets of features of activity patterns. The magnitude of response to treatment correlate with changes in patterns of activity. Patterns of activity correlate with the response to specific antidepressive treatments.
Open AccessCorrelations between patterns of activity and the response to treatment yield distinct signatures for different antidepressive treatments
Alterations in circadian patterns of activity have been described in several psychiatric disorders, and in major depressive disorder (MDD) have been associated with symptom severity. The aim of this study was to investigate the correlations between activity patterns and the response to different antidepressive treatments. We used actigraphy recordings acquired in three independent clinical trials investigating the response to internet-delivered cognitive behavioral therapy (iCBT), escitalopram, or ketamine, where symptom severity was assessed on MADRS scale. Data processing procedure was designed to extract features describing individual circadian cycles, as well as the average circadian profile for each subject. The analysis of effects of antidepressive treatments on single features (independently from magnitude of response) showed alterations in treatment-specific subsets of features. Further analysis revealed distinct correlations between longitudinal changes in individual features and the response to iCBT, escitalopram, or ketamine. Linear regression ensembles modeling the response to treatment were trained on actigraphy recorded during the depressive episode, before intervention. The analysis of coefficients following Bayesian model averaging showed that better response to iCBT was associated with weaker circadian entrainment; better response to ketamine was associated with more robust circadian entrainment and higher fragmentation of activity patterns; while higher age and steeper propensity to sustain activity was associated with better response to either iCBT or ketamine. Our data suggest that the analysis of circadian patterns of activity can potentially be used for predicting the response to specific MDD treatments, however larger confirmatory studies are required. Highlights: Different antidepressant treatments alter specific subsets of features of activity patterns. The magnitude of response to treatment correlate with changes in patterns of activity. Patterns of activity correlate with the response to specific antidepressive treatments.
- Open Access
- 10 August 2023
- Published by Springer Nature in Molecular Neurobiology
- Vol. 60 (12) , 7346-7361
Sex Differences in Long-term Outcome of Prenatal Exposure to Excess Glucocorticoids—Implications for Development of Psychiatric Disorders
Exposure to prenatal insults, such as excess glucocorticoids (GC), may lead to pathological outcomes, including neuropsychiatric disorders. The aim of the present study was to investigate the long-term effects of in utero exposure to the synthetic GC analog dexamethasone (Dex) in adult female offspring. We monitored spontaneous activity in the home cage under a constant 12 h/12 h light/dark cycle, as well as the changes following a 6-h advance of dark onset (phase shift). For comparison, we re-analysed data previously recorded in males. Dex-exposed females were spontaneously more active, and the activity onset re-entrained slower than in controls. In contrast, Dex-exposed males were less active, and the activity onset re-entrained faster than in controls. Following the phase shift, control females displayed a transient reorganisation of behaviour in light and virtually no change in dark, while Dex-exposed females showed limited variations from baseline in both light and dark, suggesting weaker photic entrainment. Next, we ran bulk RNA-sequencing in the suprachiasmatic nucleus (SCN) of Dex and control females. SPIA pathway analysis of ~ 2300 differentially expressed genes identified significantly downregulated dopamine signalling, and upregulated glutamate and GABA signalling. We selected a set of candidate genes matching the behaviour alterations and found consistent differential regulation for ~ 73% of tested genes in SCN and hippocampus tissue samples. Taken together, our data highlight sex differences in the outcome of prenatal exposure to excess GC in adult mice: in contrast to depression-like behaviour in males, the phenotype in females, defined by behaviour and differential gene expression, is consistent with ADHD models.
- 10 August 2023
- Published by Springer Nature in Molecular Neurobiology
- Vol. 60 (12) , 7346-7361
Open AccessSex Differences in Long-term Outcome of Prenatal Exposure to Excess Glucocorticoids—Implications for Development of Psychiatric Disorders
Exposure to prenatal insults, such as excess glucocorticoids (GC), may lead to pathological outcomes, including neuropsychiatric disorders. The aim of the present study was to investigate the long-term effects of in utero exposure to the synthetic GC analog dexamethasone (Dex) in adult female offspring. We monitored spontaneous activity in the home cage under a constant 12 h/12 h light/dark cycle, as well as the changes following a 6-h advance of dark onset (phase shift). For comparison, we re-analysed data previously recorded in males. Dex-exposed females were spontaneously more active, and the activity onset re-entrained slower than in controls. In contrast, Dex-exposed males were less active, and the activity onset re-entrained faster than in controls. Following the phase shift, control females displayed a transient reorganisation of behaviour in light and virtually no change in dark, while Dex-exposed females showed limited variations from baseline in both light and dark, suggesting weaker photic entrainment. Next, we ran bulk RNA-sequencing in the suprachiasmatic nucleus (SCN) of Dex and control females. SPIA pathway analysis of ~ 2300 differentially expressed genes identified significantly downregulated dopamine signalling, and upregulated glutamate and GABA signalling. We selected a set of candidate genes matching the behaviour alterations and found consistent differential regulation for ~ 73% of tested genes in SCN and hippocampus tissue samples. Taken together, our data highlight sex differences in the outcome of prenatal exposure to excess GC in adult mice: in contrast to depression-like behaviour in males, the phenotype in females, defined by behaviour and differential gene expression, is consistent with ADHD models.